366 related articles for article (PubMed ID: 10666397)
1. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.
Schumann H; Baetge J; Tasanen K; Wojnarowska F; Schäcke H; Zillikens D; Bruckner-Tuderman L
Am J Pathol; 2000 Feb; 156(2):685-95. PubMed ID: 10666397
[TBL] [Abstract][Full Text] [Related]
2. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
3. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans.
Olivry T; Dunston SM; Fahey M; Nguyen N; Marinkovich MP
Vet Pathol; 2000 Jul; 37(4):302-9. PubMed ID: 10896391
[TBL] [Abstract][Full Text] [Related]
6. IgG and IgA antibodies in linear IgA/IgG bullous dermatosis target the ectodomain of bullous pemphigoid antigen 2.
Hertl M; Büdinger L; Christophoridis S; Yancey KB; Borradori L
Br J Dermatol; 1999 Apr; 140(4):750-2. PubMed ID: 10233336
[No Abstract] [Full Text] [Related]
7. Major cleavage-dependent epitopes for linear IgA bullous dermatosis are formed at the boundary between the non-collagenous 16A and collagenous 15 domains of BP180.
Yamauchi T; Matsushita S; Hashimoto T; Hirako Y
J Dermatol Sci; 2014 Oct; 76(1):25-33. PubMed ID: 25176590
[TBL] [Abstract][Full Text] [Related]
8. Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease.
Georgi M; Scheckenbach C; Kromminga A; Partscht K; Messer G; Bröcker EB; Zillikens D
Arch Dermatol Res; 2001 Mar; 293(3):109-14. PubMed ID: 11357223
[TBL] [Abstract][Full Text] [Related]
9. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
10. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
[TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
12. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
[TBL] [Abstract][Full Text] [Related]
13. Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid.
Nishie W; Lamer S; Schlosser A; Licarete E; Franzke CW; Hofmann SC; Jackow J; Sitaru C; Bruckner-Tuderman L
J Immunol; 2010 Oct; 185(8):4938-47. PubMed ID: 20861347
[TBL] [Abstract][Full Text] [Related]
14. Equine bullous pemphigoid IgG autoantibodies target linear epitopes in the NC16A ectodomain of collagen XVII (BP180, BPAG2).
Olivry T; Borrillo AK; Xu L; Dunston SM; Slovis NM; Affolter VK; Demanuelle TC; Chan LS
Vet Immunol Immunopathol; 2000 Jan; 73(1):45-52. PubMed ID: 10678397
[TBL] [Abstract][Full Text] [Related]
15. Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid.
Yamamoto K; Inoue N; Masuda R; Fujimori A; Saito T; Imajoh-Ohmi S; Shinkai H; Sakiyama H
J Invest Dermatol; 2002 Mar; 118(3):485-92. PubMed ID: 11874488
[TBL] [Abstract][Full Text] [Related]
16. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U
J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
[TBL] [Abstract][Full Text] [Related]
17. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
Zillikens D
Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
[TBL] [Abstract][Full Text] [Related]
18. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
Mai Y; Nishie W; Izumi K; Shimizu H
Front Immunol; 2019; 10():1224. PubMed ID: 31191560
[TBL] [Abstract][Full Text] [Related]
19. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
[TBL] [Abstract][Full Text] [Related]
20. BP180/type XVII collagen: its role in acquired and inherited disorders or the dermal-epidermal junction.
Zillikens D; Giudice GJ
Arch Dermatol Res; 1999 Apr; 291(4):187-94. PubMed ID: 10335914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]